Digistain

Digistain is a UK-based company that has developed an innovative digital solution for breast cancer biomarker analytics, specifically designed to assist in the grading and prognosis of invasive breast cancer patients. The Digistain Test is a quantitative histopathology platform that has received regulatory clearance from the UK's Medicines & Healthcare products Regulatory Agency (MHRA). This AI-enabled platform aims to provide rapid risk stratification information to support multidisciplinary team (MDT) discussions, ultimately facilitating personalized treatment plans for patients while minimi…